Results for: Patanjali Ayurved

The Supreme Court of India reprimanded the Indian Medical Association (IMA) and its President, Dr. RV Asokan, for giving an interview to the press about the Court’s orders in the Patanjali misleading advertisement case. The Court stated that Asokan’s actions resembled those of Patanjali, criticizing him for lacking self-restraint. Patanjali had filed an application against Asokan, seeking judicial notice of his “wanton and unwarranted comments”. The Court also reserved its order in a contempt of court case against Patanjali Ayurved, yoga guru Baba Ramdev, and Acharya Balkrishna.

Patanjali Foods Ltd., a subsidiary of Patanjali Ayurved, is considering a proposal to acquire the non-food business of its promoter group. The acquisition may include products from dental care, home care, and personal care categories, which account for 50-60% of Patanjali Ayurved’s total revenue.

In response to the Supreme Court’s criticism of Patanjali Ayurved’s previous apology, the company has published a larger, more prominent apology in newspapers. The apology acknowledges non-compliance with the court’s orders and expresses regret for misleading advertisements. The court has also urged the government to take action against FMCG companies for misleading advertising, citing concerns about Nestle’s baby food products.

Patanjali Ayurved, in response to the Supreme Court’s questioning of the size of its previous public apology, has issued another more prominent apology in newspapers, signed by Yoga guru Ramdev and Patanjali’s managing director Acharya Balkrishna. The apology expresses remorse for non-compliance with the court’s directions and promises to abide by them in the future.

Patanjali Ayurved, along with its co-founders, has apologized in 67 newspapers for publishing “misleading” advertisements. The Supreme Court, which had previously expressed concerns, sought details about the size and cost of the apology. The court has directed Patanjali to submit copies of the advertisements for further review. The case has been adjourned for further proceedings on April 30.

The Supreme Court reprimanded the Indian Medical Association (IMA) for alleged unethical practices in recommending overpriced drugs and treatments. The court expanded the proceedings to include other fast-moving consumer goods (FMCGs) that publish misleading advertisements affecting public health, particularly infants, children, and the elderly. The Union authorities and state licensing bodies were ordered to file affidavits explaining their stance.

Yoga guru Ramdev and Patanjali Ayurved Ltd managing director Balkrishna have apologized in newspapers for misleading advertisements. The Supreme Court had warned them against degrading allopathy and ordered them to apologize publicly within a week. The court has posted the matter for hearing on April 30.

The Supreme Court has expanded the scope of a petition filed by the Indian Medical Association (IMA) against Patanjali Ayurved, also targeting other companies that publish misleading advertisements. The court directed three ministries to explain their stand on the matter and criticized the Ministry of Ayush for asking states not to take action against misleading ads.

In a landmark judgment, the Supreme Court of India has expanded its scrutiny of misleading health advertisements to include practices among doctors practicing modern medicine. The court emphasized that its actions are not solely targeted at yoga guru Ramdev and his enterprise, Patanjali Ayurved, but are motivated by broader concerns for public welfare.

The Supreme Court has criticized Patanjali Ayurved for publishing an apology that was significantly smaller than the misleading medical advertisements it ran, raising doubts about the company’s sincerity. The court directed Ramdev and Balkrishna to tender an unqualified apology in additional advertisements.